Otezla 30 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FE6J0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $58,392
Award facts
- Contract value 100% obligated
- $58,392.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $58,392.03. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a non-competitive set-aside contract and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime contract vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. Through its DLA prime contract vehicle, AmerisourceBergen serves customers including the Defense Health Agency and U.S. Coast Guard, positioning it as a key supplier within the federal pharmaceutical supply chain. The company's competitive awards and diverse product offerings reflect its ability to meet substantial federal medical supply requirements across open competition.
Quick answers
Who was awarded contract SPE2DB25FE6J0?
SPE2DB25FE6J0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FE6J0 worth?
The government has obligated $58,392 on SPE2DB25FE6J0.
Is contract SPE2DB25FE6J0 an order under another contract?
Yes. SPE2DB25FE6J0 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE6J0 competed?
The extent of competition for SPE2DB25FE6J0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award